Raytheon awarded Phalanx work
Raytheon has been awarded a $159.9 million contract by the US Department of Defense to manufacture, inspect and test Phalanx Close-in Weapon Systems (CIWS) for the US Navy, the company announced on 23 October.
The contract provides for an option worth $10 million in fiscal year 2015 and another option worth $291 million in fiscal year 2016.
Work includes the provision of support equipment for the Phalanx and SeaRAM weapon systems, Block 1B radar upgrades and kits for reliability, maintainability, and availability. The overhaul of four land-based Phalanx Weapon Systems will also be covered under the contract.
The work is expected to be completed by August 2018.
Rick Nelson, vice president, naval and area mission defense product line, Raytheon, said: ‘Phalanx provides the US Navy’s ships with a ‘last-chance’ defense against anti-ship missiles and littoral warfare threats while SeaRAM extends that inner-layer battlespace. Close-in systems give warfighters the ability to automatically carry out functions usually performed by separate systems on other ships.’
More from Naval Warfare
-
![Poland’s naval modernisation plans point to $13 billion market]()
Poland’s naval modernisation plans point to $13 billion market
Poland is reshaping its naval capabilities through investments in surface and undersea fleets, with further procurement opportunities expected into the 2030s.
-
![Autonomy gives Turkey a chance to outflank established naval shipbuilders]()
Autonomy gives Turkey a chance to outflank established naval shipbuilders
Turkish shipbuilders have sold ships from Asia to Europe, but autonomy and swarm technology could give them a fairer fight against Western European rivals.
-
![Canada assesses security equipment changes for Polar Icebreaker Imnaryuaq]()
Canada assesses security equipment changes for Polar Icebreaker Imnaryuaq
The Canadian Department of National Defence is evaluating communications and reconnaissance changes for CCGS Imnaryuaq’s expanded maritime security role, while retaining its 2032 acceptance target.
